The products being sold by the business are medical marijuana to pharmaceutical companies and our cryptocurrency KPR Coin. There is a market opportunity for the public to create capital gains through the KPR Coins they are able to invest. The 2017 legalisation of medical marijuana in Australia provides us with the best possible timing to capture the Australian market, using our respected government connections.
The KPR Coin has been through 7 months of thorough development and testing. The security levels have been met and are constantly maintained to ease the process through high performance of the transactions during the ICO and future trading. Our growth strategies include both growth of the KPR Coin value through company buybacks out of profits and through reinvestment of profits into business expansion.
The product of hemp has existed for a long period of time to generate construction materials, paper and clothing. The industry of selling medical marijuana in Australia has only had valid legislation with a licence since November 2016.
We aim to target pharmaceutical companies with the sale of our grown product and have identified markets who will buy any excess oils of our produce. This market has a potential to expand over time to recreational users.
Our target market for the KPR Coin are innovative investors looking for a cryptocurrency capital growth, rather than those with cash flow goals. As cryptocurrency expands to the larger stock exchanges, we intend to also be available to this audience.
We have a few barriers to entry including capital funding, pharmaceutical company product preferences and government legislation/licencing. Our ICO will provide the funding we need giving investors their stake in KPR Coins. We will be strongly targeting pharmaceutical companies in our sales and marketing strategies and we have been networking with New South Wales government representatives to ensure our organisation is able to demonstrate its ability to meet licencing requirements.